🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationCompounded vs brand name and honestly I cannot tell the difference — what worked for you?

Compounded vs brand name and honestly I cannot tell the difference — what worked for you?

PharmD_Rodriguez Wed, Jan 24, 2024 at 12:54 AM 12 replies 2,242 viewsPage 1 of 3
This thread is more than 28 months old. Information may be outdated. Consider searching for more recent discussions.
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Jan 24, 2024 at 12:54 AM#1

Two pharmacies quoted me last year, one describing itself as 503A and one as 503B, and I assumed 503B just meant bigger until both stopped within weeks of each other.

What I actually want to know is why a shortage listing created a legal pathway at all, since a shortage is a supply fact rather than a permission.

Happy to be told the question itself is wrong.

5 8paul_denver, TinaHashiRN, robert_kc and 2 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jan 24, 2024 at 1:02 AM#2

Short answer first, then the reasoning. Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists. For 503B the shortage clause was the only route to these molecules, so that route shut completely. A 503A pharmacy can still argue a doorway via "component of an approved drug" — but only for the substance in the form present in the approved product, which is exactly where the base-versus-salt argument lives, and it does nothing about the copy restriction, which came back into force on resolution.

6 9Dr.PulmRoch, maya_sedona, stefan_berlin and 3 others
Reply Quote Save Share Report
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Jan 24, 2024 at 1:10 AM#3
BethLabQueen said:
Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.

Agreed, and the enforcement dates were staggered by category — 503A first, 503B a few weeks later — because outsourcing facilities have manufactured inventory and clinic contracts to unwind while a 503A makes to order.

7 10HPLC_Greg, LibrarianMeg, bri_stats and 4 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Jan 24, 2024 at 1:18 AM#4
PharmD_Rodriguez said:
Two pharmacies quoted me last year, one describing itself as 503A and one as 503B, and I assumed 503B just meant bigger until both stopped within…

Can confirm the pattern PharmD_Rodriguez describes. The shortage clause is the answer to the second question and it is a subtraction rather than an addition. Both exemptions forbid compounding something that is essentially a copy of a commercially available approved product. A product FDA has listed as in shortage is not treated as commercially available, so listing removed the objection that otherwise blocked compounding. It never created a permission; it withdrew a prohibition, which is why it evaporated the moment the supply fact changed.

Last edited: Jan 24, 2024 at 4:18 AM
8 11amy_econ_NJ, bbq_ray_KC, oliver_london and 5 others
Reply Quote Save Share Report
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Jan 24, 2024 at 1:59 AM#5

Clinical perspective, offered as context rather than as advice.

Compounding pharmacy response time test for compounded supply: I email customer service at odd hours to test responsiveness. A pharmacy that can't answer questions promptly is a red flag.

My current pharmacy: average response time 1 hour. They answered my questions about batch-specific COAs thoroughly and professionally.

Communication quality is a proxy for operational quality. A pharmacy that communicates well is likely manufacturing well too.

9 12josh_phd_bmore, roxy_nash, tony_orlando and 6 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register